Jonathan I. Lieber, CFO of Rallybio Corp (RLYB), sold shares once on the open market in the last year, totaling nearly $4,000, with the latest sale on February 23, 2026. His sales rank 11,433rd among 11,678 insiders, far below the average of $8.6 million per person and 6.4 transactions. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | Rallybio Corp | $RLYB | Lieber Jonathan I | Chief Financial Officer | A | Common Stock | 2500 | $0.00 | 4,904.0000 | 45,058,591 | 103.99% | 0.01% |
| Feb. 23, 2026 | Rallybio Corp | $RLYB | Lieber Jonathan I | Chief Financial Officer | S | Common Stock | 789 | $5.06 | 4,115.0000 | 45,058,591 | 16.09% | 0.00% |
| Feb. 14, 2025 | Rallybio Corp | $RLYB | Lieber Jonathan I | Chief Financial Officer | A | Option (Right to Buy) | 180000 | $0.00 | 180,000.0000 | 43,544,824 | 9999.99% | 0.41% |
| Feb. 20, 2024 | Decoy Therapeutics Inc. | $DCOY | Lieber Jonathan I | Director | A | Stock Option (right to buy) | 20500 | $0.00 | 20,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2024 | Rallybio Corp | $RLYB | Lieber Jonathan I | Chief Financial Officer | A | Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 40,447,388 | 9999.99% | 0.30% |
| Jan. 3, 2023 | Decoy Therapeutics Inc. | $DCOY | Lieber Jonathan I | Director | A | Common Stock | 1440 | $0.00 | 2,940.0000 | 0 | 96.00% | 0.00% |